Role of Mucoadhesive Microspheres as Intra-nasal Drug Delivery

Document Type : Review Article

Authors

Department of Pharmaceutics, CMR College of Pharmacy, Hyderabad, Telangana, India.

Abstract

Carrier technology offers a innovative method for medication distribution by connecting drugs to carrier particles like liposomes, nanoparticles, or microspheres. Microspheres, with their small size and effective characteristics, are crucial in this particle medication delivery method. Mucoadhesive microspheres achieve better drug absorption by sticking to the mucosal surface and releasing the medication over an extended period. Microspheres are spherical, freely flowing, made of natural or synthetic polymers with a particle size range of 1-1000μm. Due to their unique size-dependent property and ability to include medications in carriers, lipid microspheres offer potential for novel treatments. There are several methods for preparing microspheres and releasing the medication at the intended site of action in a steady and regulated way. Due to their enhanced half-life, oral delivery capabilities, and better therapeutic responses, microspheres have gained interest in targeting and treating various illnesses. This article reviewed about the mucoadhesive microspheres, its mechanism, preparation methods and also the recent trends being achieved on mucoadhesive microspheres.

Highlights

Tadikonda Rama Rao (Google Scholar)

 

Keywords

References

1.    Sree Giri Prasad B,Gupta VRM, Devanna N, Jayasurya K. Microspheres as Drug Delivery System – A Review. Journal of Global Trends in Pharmaceutical Sciences. 2014; 5(3): 1961-1972.  
2.    Chein YW. Oral Drug Delivery Systems: In Novel drug delivery systems. Marcel Dekker, Inc., New York. 1992; Vol. 50:139- 177.
3.    Mathew Sam T, Devi Gayathri S, PrasanthVV, Vinod B. NSAIDs as microspheres, Int J Pharmacol. 2008;6(1):67-73. 
4.    Kataria Sahil et al. Microsphere: A Review. Int J Res Pharm Chem. 2011; 1(4): 1184-1198. 
5.    Gholap SB, Banarjee SK, Gaikwad DD, Jadhav SL and Thorat RM. Hollow microsphere: a review, Int J Pharm Sci Rev Res. 2010;1:74-79. 
6.    Agusundaram M, Madhu Sudana Chetty et al. Microsphere As A Novel Drug Delivery System A Review. Int J ChemTech Res. 2009;1(3):526-534. 
7.    Bhati A, Chaudhary R, Shiva , Kumar S, Mandal S. A review of advancement in Microspheres on target drug delivery system. Int J Sc Develop Res. 2021; 6(10): 1-10.
8.    Pilaniya K1, Pilaniya U2, Saharan Shyoparakash2, Saharan P2, Chandrawanshi KH. Biodegradable Solid Lipid Microparticles Loaded with Diltiazem Hydrochloride for Oral Delivery: Preparation and In- Vitro/In-Vivo Evaluation. J Drug Del Ther. 2011; 1(1):48-59. 
9.    Patel Balkrushna, Modi Vidhi, Patel Manisha. Preparation and evaluation of ethyl cellulose microspheres prepared by emulsification- solvent evaporation method. Int J Res Manage Pharm. 2012; 1(1):82-91. ISSN: 2320-0901.
10.    Ingle TG, Pande SD, Sawarkar R, Padole D. The Current Trends in Microspheres: A Review, J Drug Del Ther. 2023; 13(1):183- 194 
11.    Ankit Garg, Prashant Upadhyay. Mucoadhesive Microspheres : a short review. Asian J Pharm Clin Res. 2012; 5(3): 24-27.
12.    Parmar H, Bakliwal S, Gujarathi N, Rane B, Pawar S. Different methods of formulation and evaluation of mucoadhesive microspheres. Int J Appl Biol Pharm. 2010;1(3):1157-67.
13.    Boddupalli BM, Mohammed ZN, Nath RA, Banji D. Mucoadhesive drug delivery system: An overview. J Adv Pharm Technol Res. 2010 Oct;1(4):381-7. doi: 10.4103/0110-5558.76436. PMID: 22247877; PMCID: PMC3255397. 
14.    Alagusundaram M, Chetty MS, Umashankari K, Badarinath AV, Lavanya C, Ramkanth S. Microspheres as a novel drug delivery system: A review. Int J Chem Tech Res. 2009;1(3):526-534.
15.    Carvalho FC, Bruschi ML, Evangelista RC, Gremiao MPD. Mucoadhesive drug delivery systems. Braz J Pharm Sci. 2010; 46: 1-17.  
16.    Muthukumaran M, Dhachinamoorthi D, Chandra KBS, Sriram NA. Review On Polymers Used In Mucoadhesive Drug Delivery System. Int J Pharm Ind Res. 2011; 1(2) 122-127.
17.    Patil SB, Murthy SR, Mahajan HS, Wagh RD, Gattani SG. Mucoadhesive polymers: Means of improving drug delivery. Pharma Times. 2006; 38: 25-28.
18.    Trivedi P, Verma AML, Garud N. Preperation and Charecterization of Acclofenac Microspheres. Asian J Pharm. 2008; 2(2): 110- 115.
19.    Murtaza G, Ahamd M, Akhtar N, Rasool F. A comparative study of various microencapsulation techniques: effect of polymer viscosity on microcapsule characteristics. Pak J Pharm Sci. 2009 Jul;22(3):291-300. PMID: 19553177.
20.    Amol Chaudhari et al. An overview : Microspheres as a nasal drug delivery system. Int J Pharm Sci Rev Res. 2010;5(1): 8-17.
21.    Gu JM, Robinson JR, Leung SH. Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit Rev Ther Drug Carrier Syst. 1988;5(1):21-67. PMID: 3293807.
22.    Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005 Nov 3;57(11):1556-68. doi: 10.1016/j.addr.2005.07.001. Epub 2005 Sep 29. PMID: 16198441. 
23.    Nagai, T., Nishimoto, Y., Nambu, N., Suzuki,Y., and Sekine, K. Powder dosage form of insulin for nasal administration. J Control Release. 1984; 1: 15-22. 
24.    B. Hemalatha, M. Kalpana, B. Sree Rekha, A. Varalakshmi, K. Padmalatha. An Overview on Nasal Drug Delivery System. Asian J Pharm Res. 2022; 12(3):249-8. 
25.    Pagar Swati Appasaheb, Shinkar Dattatraya Manohar, Saudagar Ravindra Bhanudas. A Review on Intranasal Drug Delivery System. J Adv Pharm Res. 2013;3 (4):333-46.
26.    Prajapati M., Mandloi R., Pillai S, Birla N. The review on nasal drug delivery. Asian J Pharm Res. 2015; 3 (5): 110-19.  
27.    Akash H. Mali, Azam Z. Shaikh. A Short Review on Nasal Drug Delivery System. Asian J Pharm Technol. 2021; 11(4): 289-2.  
28.    Surbhi Verma, Yogita Tyagi, Pranshu Tangri. Review article on nasal drug delivery system. Int J Sci Dev Res. 2021; 6 (2): 100-7.
29.    Keller LA, Merkel O, Popp A. Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res. 2022 Apr;12(4):735-757. doi: 10.1007/s13346-020-00891-5. Epub 2021 Jan 25. PMID: 33491126; PMCID: PMC7829061. 
30.    Parmar Harshad, Bhandari Anand, Shah Dushyant. Recent techniques in nasal drug delivery: A review. Int J Drug Dev Res. 2010; 2(3): 565-72.
31.    Sulaiman alnasser. A review on nasal drug delivery system and its contribution in therapeutic management. Asian J Pharm Clin Res. 2019;12(1): 40-45.  
32.    Aulton ME. Pharmaceutics – The Science of Dosage form Design. New York: Churchill Livingston; 2002. p. 494.
33.    Johnson NJ, Hanson LR, Frey WH. Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures. Mol Pharm. 2010 Jun 7;7(3):884-93. doi: 10.1021/mp100029t. PMID: 20420446; PMCID: PMC2892271. 
34.    Svensson S, Olin AC, Hellgren J. Increased net water loss by oral compared to nasal expiration in healthy subjects. Rhinology. 2006 Mar;44(1):74-7. PMID: 16550955.
35.    Pagar Swati Appasaheb, Shinkar Dattatraya Manohar, Saudagar Ravindra Bhanudas. A Review on Intranasal Drug Delivery System; J Adv Pharm Edu. & Res. 2013: 3(4): 333-346. 
36.    Machida M, Sano K, Arakawa M, Hayashi M, Awazu S. Effects of surfactants and protease inhibitors on nasal absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats. Biol Pharm Bull. 1994 Oct;17(10):1375-8. doi: 10.1248/bpb.17.1375. PMID: 7533020. 
37.    Gannu Praveen Kumar, Kiran S. Strategies and prospects of nasal drug delivery systems. Indian J Pharm Sci Res. 2012; 2(1):33-41.  
38.    Ozsoy Y, Gungor S, Cevher E. Nasal delivery of high molecular weight drugs. Molecules. 2009 Sep 23;14(9):3754-79. doi: 10.3390/molecules14093754. PMID: 19783956; PMCID: PMC6254717.
39.    Corbo DC, Liu JC, Chien YW. Characterization of the barrier properties of mucosal membranes. J Pharm Sci. 1990 Mar;79(3):202-6. doi: 10.1002/jps.2600790304. PMID: 2338626. 
40.    Sakane T, Akizuki M, Yamashita S, Nadai T, Hashida M, Sezaki H. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. Chem Pharm Bull (Tokyo). 1991 Sep;39(9):2456-8. doi: 10.1248/cpb.39.2456. PMID: 1804561. 
41.    Ohwaki K, Ando H, Watanabe S, Miyake Y. Effects of Krenistsky, Amino acid ester prodrugs of acyclovir, Antiviral dose, pH, and osmolarity on nasal absorption of secretin in Chem. Chemother., 1992;3:157–164.
42.    Behl C,R., Pimplaskar N.K., Sileno A.P., Demeireles J., Romeo VD. Effect of physicochemical properties and other factors on nasal drug delivery. Adv Drug Del Rev. 1998; 89-116.  
43.    Clement P, Roovers MH, Francillon C, Dodion P. Dose-ranging, placebo-controlled study of cetirizine nasal spray in adults with perennial allergic rhinitis. Allergy. 1994 Sep;49(8):668-72. doi: 10.1111/j.1398-9995.1994.tb00138.x. PMID: 7653747. 
44.    Ibrahim A, Alsarra A., Hamed, Fars KA, Gamal M, Maghraby E. Vesicular Systems for Intranasal Drug Delivery, K.K. Jain (ed.), Drug Delivery to the Central Nervous System, Neuromethods. 2009 45. 
45.    Talegaonkar S, Mishra PR. Intranasal delivery: An approach to bypass the blood brain  barrier. Indian J Pharm. 2004;36:140-7.
46.    Hussein NR. Bioadhesive Microparticles and Liposomes of AntiParkinson Drugs for Nasal Delivery. Ph.D. Thesis, University of Central Lancashire; 2014.
47.    Chajed S, Sangle S, Barhate S. Advantagious nasal drug delivery system - A review. Int J Pharm Sci Res. 2011;2:1322-6.
48.    Chaturvedi M, Kumar M, Pathak K. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res. 2011 Oct;2(4):215-22. doi: 10.4103/2231-4040.90876. PMID: 22247888; PMCID: PMC3255357.
Trends in Pharmaceutical Sciences
Volume 10, Issue 2
June 2024
Pages 153-164

Files

Share

How to cite

Statistics